TR
EN
Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report
Abstract
The hemolysis side effect of selective serotonin reuptake inhibitors is potentially lethal, although not much has been reported. We hereby report a 43-year-old male case of hemolytic anemia that developed after use of citalopram 40 mg/day and its improvement with discontinuation. Further studies should be conducted to provide a greater understanding of both its prevalence and etiology.
Keywords
References
- 1. Nemeroff CB. Overview of the safety of citalopram. Psychopharmacol Bull. 2003;37:96-121.
- 2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; Author: Washington, DC, 2013.
- 3. Kose S, Akin E, Cetin M. Adverse drug reactions and causality: The Turkish version of Naranjo Adverse Drug Reactions Probability Scale. Psychiatry Clin Psychopharmacol. 2017;27:205-6.
- 4. Edwards IR, Biriell C. Harmonisation in pharmacovigilance. Drug Saf. 1994;10:93-102.
- 5. Pierce A, Nester T, Education Committee of the Academy of Clinical Laboratory Physicians and Scientists. Am J Clin Pathol. 2011;136:7-12.
- 6. Jilani K, Enkel S, Bissinger R, et al. Fluoxetine induced suicidal erythrocyte death. Toxins (Basel). 2013;5:1230-43.
- 7. Garraty G. Immune hemolytic anemia associated with drug therapy. Blood Rev. 2010;24:143-50.
Details
Primary Language
English
Subjects
Internal Diseases
Journal Section
Case Report
Authors
Publication Date
March 20, 2020
Submission Date
January 7, 2020
Acceptance Date
March 10, 2020
Published in Issue
Year 2020 Volume: 5 Number: 1
APA
Örüm, M. H. (2020). Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report. Archives of Clinical and Experimental Medicine, 5(1), 35-37. https://doi.org/10.25000/acem.671598
AMA
1.Örüm MH. Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report. Arch Clin Exp Med. 2020;5(1):35-37. doi:10.25000/acem.671598
Chicago
Örüm, Mehmet Hamdi. 2020. “Life-Threatening Citalopram Induced Hemolytic Anemia in a Patient With Generalized Anxiety Disorder: A Case Report”. Archives of Clinical and Experimental Medicine 5 (1): 35-37. https://doi.org/10.25000/acem.671598.
EndNote
Örüm MH (March 1, 2020) Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report. Archives of Clinical and Experimental Medicine 5 1 35–37.
IEEE
[1]M. H. Örüm, “Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report”, Arch Clin Exp Med, vol. 5, no. 1, pp. 35–37, Mar. 2020, doi: 10.25000/acem.671598.
ISNAD
Örüm, Mehmet Hamdi. “Life-Threatening Citalopram Induced Hemolytic Anemia in a Patient With Generalized Anxiety Disorder: A Case Report”. Archives of Clinical and Experimental Medicine 5/1 (March 1, 2020): 35-37. https://doi.org/10.25000/acem.671598.
JAMA
1.Örüm MH. Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report. Arch Clin Exp Med. 2020;5:35–37.
MLA
Örüm, Mehmet Hamdi. “Life-Threatening Citalopram Induced Hemolytic Anemia in a Patient With Generalized Anxiety Disorder: A Case Report”. Archives of Clinical and Experimental Medicine, vol. 5, no. 1, Mar. 2020, pp. 35-37, doi:10.25000/acem.671598.
Vancouver
1.Mehmet Hamdi Örüm. Life-threatening citalopram induced hemolytic anemia in a patient with generalized anxiety disorder: A case report. Arch Clin Exp Med. 2020 Mar. 1;5(1):35-7. doi:10.25000/acem.671598
Cited By
Design, synthesis and cytotoxic evaluation of a selective serotonin reuptake inhibitor (SSRI) by virtual screening
European Journal of Pharmaceutical Sciences
https://doi.org/10.1016/j.ejps.2023.106403Comparative evaluation of green and black olive extracts in alleviating the cigarette smoke-stimulated inflammation
Journal of Agriculture and Food Research
https://doi.org/10.1016/j.jafr.2025.102005